Welcome to Sabbiotech!     
Email:info@signalwayantibody.com
Location: Home > Conjugated Antibodies > VEGF Conjugated Antibody

VEGF Conjugated Antibody#C48707

Availability: 1-2 weeks
Total Amount:$
Product Detail

Product NameVEGF Conjugated Antibody

Host SpeciesRabbit

ClonalityMonoclonal

Species ReactivityHu, Ms, Rt

Immunogen Descrecombinant protein

ConjugateAF Dye

Excitation EmissionAF350: 346nm/442nm
AF405: 401nm/421nm
AF488: 493nm/519nm
AF555: 555nm/565nm
AF594: 591nm/614nm
AF647: 651nm/667nm
AF680: 679nm/702nm
AF750: 749nm/775nm

Other NamesFolliculostellate cell-derived growth factor antibody
Glioma-derived endothelial cell mitogen antibody
MGC70609 antibody
MVCD1 antibody
Vascular endothelial growth factor A antibody
vascular endothelial growth factor A121 antibody
vascular endothelial growth factor A165 antibody
vascular endothelial growth factor antibody
Vascular permeability factor antibody
VEGF A antibody
Vegf antibody
VEGF-A antibody
VEGF120 antibody
Vegfa antibody
VEGFA_HUMAN antibody
VPF antibody

Accession NoSwiss-Prot#:P15692

Uniprot P15692

Gene ID 7422;

Calculated MW43 kDa

Formulation0.01M Sodium Phosphate, 0.25M NaCl, pH 7.6, 5mg/ml Bovine Serum Albumin, 0.02% Sodium Azide

StorageStore at 4˚C in dark for 6 months

Application Details
Suggested Dilution:
AF350 conjugated: most applications: 1: 50 - 1: 250
AF405 conjugated: most applications: 1: 50 - 1: 250
AF488 conjugated: most applications: 1: 50 - 1: 250
AF555 conjugated: most applications: 1: 50 - 1: 250
AF594 conjugated: most applications: 1: 50 - 1: 250
AF647 conjugated: most applications: 1: 50 - 1: 250
AF680 conjugated: most applications: 1: 50 - 1: 250
AF750 conjugated: most applications: 1: 50 - 1: 250
Biotin conjugated: working with enzyme-conjugated streptavidin, most applications: 1: 50 - 1: 1,000
The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast growth factors (FGFs), platelet derived growth factor (PDGF) and vascular endothelial growth factor (VEGF). VEGF is a dimeric glycoprotein with structural homology to PDGF. Several variants of VEGF have been described that arise by alternative mRNA splicing. It has been speculated that VEGF may function as a tumor angiogenesis factor in vivo because the expression pattern of VEGF is consistent with a role in embryonic angiogenesis. VEGF mRNA is formed in some primary tumors, VEGF is produced by tumor cell lines in vitro and VEGF mitogenic activity appears to be restricted to endothelial cells. A member of the PDGF receptor family, Flt, has been identified as a high-affinity receptor for VEGF.

If you have published an article using product C48707, please notify us so that we can cite your literature.

et al,Enhancing HepG2 cell apoptosis with a combined nanoparticle delivery of miR-128-3p agomir and Oroxin B: A novel drug delivery approach based on PI3K-AKT and VEGF pathway crosstalk , (2024),
PMID:

NOTE

Application

  • WBWestern Blotting
  • IHCImmunohistochemistry
  • IFImmunofluorescence
  • ICCImmunocytochemistry
  • FCFlow Cytometry
  • IPImmunoprecipitation
  • EELISA
  • DBDot Blotting
  • ChIPChromatin Immunoprecipitation
  • GICAGold Immunochromatography Assay
  • NCNegative Control

Species Reactivity

  • HuHuman
  • MsMouse
  • RtRat
  • DmDrosophila melanogaster
  • CCaenorhabditis elegans
  • MkMonkey
  • RbRabbit
  • BBovine
  • DDog
  • PPig
  • HmHamster
  • ChHmChinese Hamster
  • ChkChicken
  • ShpSheep
;